New insights from a systematic review and meta-analysis on the treatment of difficult-to-treat rheumatoid arthritis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
New insights from a systematic review and meta-analysis on the treatment of difficult-to-treat rheumatoid arthritis ; volume:22 ; number:1 ; day:11 ; month:10 ; year:2024 ; pages:1-2 ; date:12.2024
Journal of translational medicine ; 22, Heft 1 (11.10.2024), 1-2, 12.2024
- Urheber
-
He, Xianyao
Wu, Anqi
Pang, Xianlun
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-024-05721-7
- URN
-
urn:nbn:de:101:1-2412302117484.943311937006
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- He, Xianyao
- Wu, Anqi
- Pang, Xianlun
- SpringerLink (Online service)
Ähnliche Objekte (12)
Is Baricitinib Effective and Safe for Patients with Difficult-to-Treat Rheumatoid Arthritis? Comparative Data with the Rheumatoid Arthritis Group of Rheumatoid Arthritis Not Difficult to Treat
The potential role of fatigue in difficult-to-treat rheumatoid arthritis
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
Difficult-to-Treat Rheumatoid Arthritis in Older Adults: Implications of Ageing for Managing Patients
Characteristics of patients with difficult-to-treat rheumatoid arthritis: a descriptive retrospective cohort study
Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis
Efficacy and safety of current therapies for difficult-to-treat rheumatoid arthritis: a systematic review and network meta-analysis
Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry
Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat rheumatoid arthritis patients: from the FIRST Registry
Not all geriatric cachexia is cancer – The difficult lateonset rheumatoid arthritis
Identification and prediction of difficult-to-treat rheumatoid arthritis patients in structured and unstructured routine care data: results from a hackathon
Total hip arthroplasty to treat acetabular protrusions secondary to rheumatoid arthritis
Is Baricitinib Effective and Safe for Patients with Difficult-to-Treat Rheumatoid Arthritis? Comparative Data with the Rheumatoid Arthritis Group of Rheumatoid Arthritis Not Difficult to Treat
The potential role of fatigue in difficult-to-treat rheumatoid arthritis
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
Difficult-to-Treat Rheumatoid Arthritis in Older Adults: Implications of Ageing for Managing Patients
Characteristics of patients with difficult-to-treat rheumatoid arthritis: a descriptive retrospective cohort study
Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis
Efficacy and safety of current therapies for difficult-to-treat rheumatoid arthritis: a systematic review and network meta-analysis
Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry
Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat rheumatoid arthritis patients: from the FIRST Registry
Not all geriatric cachexia is cancer – The difficult lateonset rheumatoid arthritis
Identification and prediction of difficult-to-treat rheumatoid arthritis patients in structured and unstructured routine care data: results from a hackathon
Total hip arthroplasty to treat acetabular protrusions secondary to rheumatoid arthritis
Is Baricitinib Effective and Safe for Patients with Difficult-to-Treat Rheumatoid Arthritis? Comparative Data with the Rheumatoid Arthritis Group of Rheumatoid Arthritis Not Difficult to Treat
The potential role of fatigue in difficult-to-treat rheumatoid arthritis
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
Difficult-to-Treat Rheumatoid Arthritis in Older Adults: Implications of Ageing for Managing Patients
Characteristics of patients with difficult-to-treat rheumatoid arthritis: a descriptive retrospective cohort study
Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis
Efficacy and safety of current therapies for difficult-to-treat rheumatoid arthritis: a systematic review and network meta-analysis
Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry
Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat rheumatoid arthritis patients: from the FIRST Registry
Not all geriatric cachexia is cancer – The difficult lateonset rheumatoid arthritis
Identification and prediction of difficult-to-treat rheumatoid arthritis patients in structured and unstructured routine care data: results from a hackathon